Analgesic drug interim analysis shows long-acting PK, safety profile: Nektar
NKTR-181, a mu-opioid analgesic investigational drug candidate, was created using Nektar’s small molecule polymer conjugate technology. The Phase 1 study is assessing the pharmacokinetics, pharmacology, safety and efficacy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.